Vertex Pharmaceuticals Incorporated (VRTX) CEO Reshma Kewalramani on Q2 2021 Results - Earnings Call TranscriptSeeking Alpha • 07/30/21
Vertex Pharmaceuticals (VRTX) Q2 Earnings and Revenues Surpass EstimatesZacks Investment Research • 07/29/21
Vertex to Initiate Phase 3 Development Program for New Once-Daily Triple Combination Regimen in People With Cystic FibrosisBusiness Wire • 07/28/21
Vertex Initiates Phase 2 Clinical Trial Program for VX-548 for the Treatment of Acute PainBusiness Wire • 07/19/21